Aimilia D. Sklirou

Age‐dependent and gender‐dependent antibody responses against <scp>SARS‐CoV</scp>‐2 in health workers and octogenarians after vaccination with the <scp>BNT162b2 mRNA</scp> vaccine

Evangelos Terpos, Ioannis P. Trougakos, Filia Apostolakou et al. · American Journal of Hematology · 2021 · 156 citations · Full text

Vaccination, Vaccine Safety, Vaccinology +14

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose

Evangelos Terpos, Ioannis P. Trougakos, Maria Gavriatopoulou et al. · Blood · 2021 · 144 citations · Full text

6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts

Aimilia D. Sklirou, Nicolas Gaboriaud‐Kolar, Issidora S. Papassideri et al. · Scientific Reports · 2017 · 65 citations · Full text

Chemoprevention Strategy, Lipid Peroxidation, Cell Death +20

Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients

Ioannis P. Trougakos, Evangelos Terpos, Christina Zirou et al. · BMC Medicine · 2021 · 57 citations · Full text

Comparison survey of EVOO polyphenols and exploration of healthy aging-promoting properties of oleocanthal and oleacein

Vasiliki Liaki, Panagiotis Stathopoulos, Aimilia D. Sklirou et al. · Food and Chemical Toxicology · 2019 · 49 citations

Food Chemistry, Polyphenolics, Healthy Aging-promoting Properties +10